ES2052066T3 - Mejoras en o relacionadas con compuestos organicos. - Google Patents

Mejoras en o relacionadas con compuestos organicos.

Info

Publication number
ES2052066T3
ES2052066T3 ES89810809T ES89810809T ES2052066T3 ES 2052066 T3 ES2052066 T3 ES 2052066T3 ES 89810809 T ES89810809 T ES 89810809T ES 89810809 T ES89810809 T ES 89810809T ES 2052066 T3 ES2052066 T3 ES 2052066T3
Authority
ES
Spain
Prior art keywords
organic compounds
immunostimulatory
compounds
poliinsaturados
omosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810809T
Other languages
English (en)
Inventor
J Wesley Alexander
Vigen K Babayan
George L Blackburn
Frank B Cerra
John M Daly
Mitchell T Gersovitz
John E Kinsella
Jerome J Licari
Frederick Rudolph
Buren Charles T Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz Nutrition AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Nutrition AG filed Critical Sandoz Nutrition AG
Application granted granted Critical
Publication of ES2052066T3 publication Critical patent/ES2052066T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO SUMINISTRA COMPUESTOS INMUNOESTIMULATORIOS QUE COMPRENDEN UNA CANTIDAD INMUNOESTIMULATORIA DE AGREGADO DE: A)UN COMPUESTO ASOCIADO CON LA SINTESIS DE POLIAMINAS, B)UNA FUENTE DE NUCLEO - BASE, C)ACIDOS GRASOS OMEGA-3 POLIINSATURADOS, D)ACIDOS GRASOS OMEGA-6 POLIINSATURADOS, TAMBIEN SE PRESENTA EL USO DE TALES COMPUESTOS Y SU MANUFACTURA.
ES89810809T 1988-10-31 1989-10-27 Mejoras en o relacionadas con compuestos organicos. Expired - Lifetime ES2052066T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26537388A 1988-10-31 1988-10-31
US30587789A 1989-02-02 1989-02-02
US42104589A 1989-10-13 1989-10-13

Publications (1)

Publication Number Publication Date
ES2052066T3 true ES2052066T3 (es) 1994-07-01

Family

ID=27401801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810809T Expired - Lifetime ES2052066T3 (es) 1988-10-31 1989-10-27 Mejoras en o relacionadas con compuestos organicos.

Country Status (8)

Country Link
EP (1) EP0367724B1 (es)
JP (1) JP2520488B2 (es)
AU (1) AU626930B2 (es)
CA (1) CA2001727C (es)
DE (1) DE68904874T2 (es)
DK (1) DK172673B1 (es)
ES (1) ES2052066T3 (es)
HK (1) HK34694A (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US6020317A (en) * 1993-02-19 2000-02-01 Nippon Shinyaku Co. Ltd. Glycerol derivative, device and pharmaceutical composition
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US6455068B1 (en) 1995-12-26 2002-09-24 Onesta Nutrition, Inc. Dietary fiber delivery system
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
EP0960572A1 (en) 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
PT1390378E (pt) * 2001-04-30 2009-07-23 Trommsdorff Arzneimittel Ésteres de uridina farmaceuticamente activos
US20060280776A1 (en) 2003-09-02 2006-12-14 Masafumi Koide Diet food
AU2004273759A1 (en) * 2003-09-19 2005-03-31 N.V. Nutricia Method and composition for preventing multiple organ dysfunction syndrome
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
ES2548432T3 (es) 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
DK1800675T3 (da) * 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
ES2341163B1 (es) 2008-09-26 2011-05-11 Bioiberica, S.A. Composiciones inmunoestimulantes.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ カルシウムｈｍｂを含む栄養エマルジョン
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
JPS6284028A (ja) * 1985-07-26 1987-04-17 イエダ・リサ−チ・アンド・デイベロツプメント・カンパニ−・リミテツド 膜流動化のための脂質混合物
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products

Also Published As

Publication number Publication date
EP0367724B1 (en) 1993-02-10
DE68904874D1 (de) 1993-03-25
DK172673B1 (da) 1999-05-10
CA2001727C (en) 1998-02-17
AU4386089A (en) 1990-05-03
HK34694A (en) 1994-04-22
DK540389A (da) 1990-05-01
JPH02191213A (ja) 1990-07-27
DE68904874T2 (de) 1993-07-15
CA2001727A1 (en) 1990-04-30
AU626930B2 (en) 1992-08-13
JP2520488B2 (ja) 1996-07-31
DK540389D0 (da) 1989-10-30
EP0367724A1 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
ES2052066T3 (es) Mejoras en o relacionadas con compuestos organicos.
MY104685A (en) Substituted thiazoles and their use as fungicides.
ES2075129T3 (es) Preparacion de gel que contiene estrogeno.
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
DE68914856D1 (de) Synergetische Antioxydationsmischung.
ES1020791Y (es) Butaca con auxilio para levantarse.
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
MX174161B (es) Una forma de dosis para suministrar el farmaco benefico verapamil
DE68902629D1 (de) Orale zusammensetzung.
DE68924470D1 (de) Fettzusammensetzungen mit hohem Fettkörpergehalt.
DE68921182D1 (de) Bleichmittelzusammensetzung.
AR243913A1 (es) Aditivo reologico de poliamida, una solucion que contiene el aditivo y composiciones espesadas que contienen el aditivo.
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
KR910000114A (ko) 멜라닌 생성 억제 외용제
ES2130598T3 (es) Preparaciones cosmeticas y/o farmaceuticas.
FI893952L (fi) Braenslekompositioner.
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
DE68909636D1 (de) Adhäsive Zusammensetzung.
AR004476A1 (es) Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ES2085051T3 (es) Usos de 1,1,1,3,3,3-hexafluoropropano.
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367724

Country of ref document: ES